Dutch Top Stock Picks from Analysts

Prosus

Market Cap: €86.4b

Engages in the e-commerce and internet businesses in Asia, Europe, Latin America, North America, and internationally.

Adyen

Market Cap: €26.0b

Operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America.

Heineken Holding

Market Cap: €18.2b

Engages in brewing and selling beer and cider in the Netherlands, Europe, the Americas, Africa & Middle East, Asia Pacific and internationally.

Exor

Market Cap: €13.5b

Engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally.

Wolters Kluwer

Market Cap: €12.8b

Provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally.

CSG

Market Cap: €12.7b

Manufactures and sells defence products in the Czech Republic, Europe, the United States, and the Asia Pacific.

Pharming Group

Market Cap: €823.5m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Ferrari Group

Market Cap: €657.4m

Provides shipping, integrated logistics, and value-added services for jewelry and precious goods in Europe, Asia, North America, Brazil, and internationally.

Envipco Holding

Market Cap: €247.8m

Develops, manufactures, assembles, leases, sells, markets, and services a line of reverse vending machines (RVMs) in the Netherlands, the United States, North America, and Europe.

Avantium

Market Cap: €192.3m

A chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands.

Cabka

Market Cap: €48.2m

Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.

Vivoryon Therapeutics

Market Cap: €32.0m

Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.